Literature DB >> 8088073

Central nervous system lupus: concomitant occurrence of myelopathy and cognitive dysfunction.

H D Stahl1, T H Ettlin, A Plohmann, E W Radü, J Müller-Brand, U Steiger, A Tyndall.   

Abstract

Reported are two cases of patients with central nervous system systemic lupus erythematosus (SLE) with clinical features of a myelopathy confirmed by magnetic resonance imaging (MRI). In one case, further evaluation including Single Photon Emission Computerized Tomography (SPECT) and neuropsychological testing, indicated higher cortical deficits which improved after treatment with monthly pulse intravenous cyclophosphamide. Subsequent cessation of cyclophosphamide was associated with further progression of the neurological disease in this patient.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8088073     DOI： 10.1007/bf02249026

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  16 in total

1.  Response to intravenous cyclophosphamide treatment in lupus myelopathy.

Authors:  B Berlanga; F R Rubio; I Moga; V Pac
Journal:  J Rheumatol       Date:  1992-05       Impact factor: 4.666

2.  Transverse myelitis in systemic lupus erythematosus: two cases with magnetic resonance imaging.

Authors:  C P Simeon-Aznar; C Tolosa-Vilella; R Cuenca-Luque; R Jordana-Comajuncosa; J Ordi-Ros; J A Bosch-Gil
Journal:  Br J Rheumatol       Date:  1992-08

3.  Central nervous system lupus erythematosus. The need for classification.

Authors:  S S Kassan; M D Lockshin
Journal:  Arthritis Rheum       Date:  1979-12

4.  MRI and SPECT investigations of the CNS in SLE patients.

Authors:  L Emmi; M Bramati; M T De Cristofaro; M Mascalchi; G Dal Pozzo; G P Marconi; G Massai; A Passaleva
Journal:  Clin Exp Rheumatol       Date:  1993 Jan-Feb       Impact factor: 4.473

5.  Transverse myelitis and acute central nervous system manifestations of systemic lupus erythematosus.

Authors:  R W Warren; D W Kredich
Journal:  Arthritis Rheum       Date:  1984-09

Review 6.  Acute transverse myelitis in systemic lupus erythematosus: magnetic resonance imaging and review of the literature.

Authors:  D T Boumpas; N J Patronas; M C Dalakas; C A Hakim; J H Klippel; J E Balow
Journal:  J Rheumatol       Date:  1990-01       Impact factor: 4.666

7.  A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus.

Authors:  K S Ginsburg; E A Wright; M G Larson; A H Fossel; M Albert; P H Schur; M H Liang
Journal:  Arthritis Rheum       Date:  1992-07

8.  Cerebral blood flow variations in CNS lupus.

Authors:  M J Kushner; M Tobin; F Fazekas; J Chawluk; D Jamieson; B Freundlich; S Grenell; L Freemen; M Reivich
Journal:  Neurology       Date:  1990-01       Impact factor: 9.910

9.  Cognitive impairment in systemic lupus erythematosus: a neuropsychological study of individual and group deficits.

Authors:  S D Denburg; R M Carbotte; J A Denburg
Journal:  J Clin Exp Neuropsychol       Date:  1987-08       Impact factor: 2.475

10.  Technetium-99m d,l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion.

Authors:  R D Neirinckx; L R Canning; I M Piper; D P Nowotnik; R D Pickett; R A Holmes; W A Volkert; A M Forster; P S Weisner; J A Marriott
Journal:  J Nucl Med       Date:  1987-02       Impact factor: 10.057
View more
  2 in total

1.  99m-Tc-HMPAO-SPECT in diagnosis of early cerebral vasculitis.

Authors:  S Meusser; A Rubbert; B Manger; E Bock; G Platsch; H Feistel; A Engelhardt; F Wolf; J R Kalden
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

2.  Concomitant occurrence of cervical myelopathy, cerebral infarction, and peripheral neuropathy in systemic lupus erythematosus: a case report.

Authors:  So-Yeon Kim; Tae-Sik Yoon; Jee-Hyun Suh
Journal:  Ann Rehabil Med       Date:  2014-04-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.